nodes	percent_of_prediction	percent_of_DWPC	metapath
Aclidinium—CHRM2—Dimenhydrinate—atopic dermatitis	0.378	0.499	CbGbCtD
Aclidinium—BCHE—Triamcinolone—atopic dermatitis	0.195	0.257	CbGbCtD
Aclidinium—CHRM2—Diphenhydramine—atopic dermatitis	0.185	0.244	CbGbCtD
Aclidinium—Toothache—Pimecrolimus—atopic dermatitis	0.00783	0.0371	CcSEcCtD
Aclidinium—Dysphonia—Mometasone—atopic dermatitis	0.00396	0.0187	CcSEcCtD
Aclidinium—Infestation NOS—Desonide—atopic dermatitis	0.00377	0.0179	CcSEcCtD
Aclidinium—Infestation—Desonide—atopic dermatitis	0.00377	0.0179	CcSEcCtD
Aclidinium—Nasopharyngitis—Fluocinonide—atopic dermatitis	0.00355	0.0168	CcSEcCtD
Aclidinium—Urinary retention—Dimenhydrinate—atopic dermatitis	0.0034	0.0161	CcSEcCtD
Aclidinium—Urinary retention—Diphenhydramine—atopic dermatitis	0.0034	0.0161	CcSEcCtD
Aclidinium—Nasopharyngitis—Pimecrolimus—atopic dermatitis	0.00309	0.0146	CcSEcCtD
Aclidinium—Mediastinal disorder—Desonide—atopic dermatitis	0.00305	0.0145	CcSEcCtD
Aclidinium—Infestation NOS—Pimecrolimus—atopic dermatitis	0.00266	0.0126	CcSEcCtD
Aclidinium—Infestation—Pimecrolimus—atopic dermatitis	0.00266	0.0126	CcSEcCtD
Aclidinium—Cough—Desonide—atopic dermatitis	0.00257	0.0122	CcSEcCtD
Aclidinium—Sinusitis—Pimecrolimus—atopic dermatitis	0.0025	0.0118	CcSEcCtD
Aclidinium—Rhinitis—Pimecrolimus—atopic dermatitis	0.0024	0.0114	CcSEcCtD
Aclidinium—Infection—Desonide—atopic dermatitis	0.00239	0.0113	CcSEcCtD
Aclidinium—Nervous system disorder—Desonide—atopic dermatitis	0.00236	0.0112	CcSEcCtD
Aclidinium—Eye disorder—Pimecrolimus—atopic dermatitis	0.00223	0.0106	CcSEcCtD
Aclidinium—Nasopharyngitis—Fluocinolone Acetonide—atopic dermatitis	0.00221	0.0105	CcSEcCtD
Aclidinium—Diabetes mellitus—Tacrolimus—atopic dermatitis	0.00216	0.0102	CcSEcCtD
Aclidinium—Mediastinal disorder—Pimecrolimus—atopic dermatitis	0.00216	0.0102	CcSEcCtD
Aclidinium—Nasopharyngitis—Mometasone—atopic dermatitis	0.00211	0.01	CcSEcCtD
Aclidinium—Vision blurred—Diphenhydramine—atopic dermatitis	0.00203	0.00961	CcSEcCtD
Aclidinium—Vision blurred—Dimenhydrinate—atopic dermatitis	0.00203	0.00961	CcSEcCtD
Aclidinium—Infection—Fluocinonide—atopic dermatitis	0.00194	0.00917	CcSEcCtD
Aclidinium—Cardiac failure—Tacrolimus—atopic dermatitis	0.00193	0.00913	CcSEcCtD
Aclidinium—Nervous system disorder—Fluocinonide—atopic dermatitis	0.00191	0.00905	CcSEcCtD
Aclidinium—Infestation NOS—Fluocinolone Acetonide—atopic dermatitis	0.00191	0.00903	CcSEcCtD
Aclidinium—Infestation—Fluocinolone Acetonide—atopic dermatitis	0.00191	0.00903	CcSEcCtD
Aclidinium—Osteoarthritis—Tacrolimus—atopic dermatitis	0.00188	0.00891	CcSEcCtD
Aclidinium—Cough—Pimecrolimus—atopic dermatitis	0.00182	0.00861	CcSEcCtD
Aclidinium—Dry mouth—Dimenhydrinate—atopic dermatitis	0.00179	0.00849	CcSEcCtD
Aclidinium—Dry mouth—Diphenhydramine—atopic dermatitis	0.00179	0.00849	CcSEcCtD
Aclidinium—Sinusitis—Fluocinolone Acetonide—atopic dermatitis	0.00179	0.00848	CcSEcCtD
Aclidinium—Urinary retention—Tacrolimus—atopic dermatitis	0.00179	0.00847	CcSEcCtD
Aclidinium—Rhinitis—Fluocinolone Acetonide—atopic dermatitis	0.00172	0.00813	CcSEcCtD
Aclidinium—Tachycardia—Dimenhydrinate—atopic dermatitis	0.00171	0.00812	CcSEcCtD
Aclidinium—Tachycardia—Diphenhydramine—atopic dermatitis	0.00171	0.00812	CcSEcCtD
Aclidinium—Sinusitis—Mometasone—atopic dermatitis	0.00171	0.00809	CcSEcCtD
Aclidinium—Infection—Pimecrolimus—atopic dermatitis	0.00169	0.008	CcSEcCtD
Aclidinium—Nervous system disorder—Pimecrolimus—atopic dermatitis	0.00167	0.00789	CcSEcCtD
Aclidinium—Rhinitis—Mometasone—atopic dermatitis	0.00164	0.00776	CcSEcCtD
Aclidinium—Eye disorder—Fluocinolone Acetonide—atopic dermatitis	0.0016	0.00758	CcSEcCtD
Aclidinium—Mediastinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.00154	0.00731	CcSEcCtD
Aclidinium—Headache—Desonide—atopic dermatitis	0.00151	0.00714	CcSEcCtD
Aclidinium—Mediastinal disorder—Mometasone—atopic dermatitis	0.00147	0.00698	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Pimecrolimus—atopic dermatitis	0.00147	0.00695	CcSEcCtD
Aclidinium—Infestation—Tacrolimus—atopic dermatitis	0.00145	0.00687	CcSEcCtD
Aclidinium—Infestation NOS—Tacrolimus—atopic dermatitis	0.00145	0.00687	CcSEcCtD
Aclidinium—Cough—Loratadine—atopic dermatitis	0.00145	0.00685	CcSEcCtD
Aclidinium—Vision blurred—Fluocinolone Acetonide—atopic dermatitis	0.0014	0.00665	CcSEcCtD
Aclidinium—Diabetes mellitus—Prednisolone—atopic dermatitis	0.00138	0.00654	CcSEcCtD
Aclidinium—Dry mouth—Loratadine—atopic dermatitis	0.00138	0.00654	CcSEcCtD
Aclidinium—Sinusitis—Tacrolimus—atopic dermatitis	0.00136	0.00644	CcSEcCtD
Aclidinium—Diabetes mellitus—Hydrocortisone—atopic dermatitis	0.00135	0.00639	CcSEcCtD
Aclidinium—Nervous system disorder—Loratadine—atopic dermatitis	0.00133	0.00629	CcSEcCtD
Aclidinium—Tachycardia—Loratadine—atopic dermatitis	0.00132	0.00626	CcSEcCtD
Aclidinium—Rhinitis—Tacrolimus—atopic dermatitis	0.0013	0.00618	CcSEcCtD
Aclidinium—Cough—Fluocinolone Acetonide—atopic dermatitis	0.0013	0.00616	CcSEcCtD
Aclidinium—Urinary tract disorder—Tacrolimus—atopic dermatitis	0.00128	0.00609	CcSEcCtD
Aclidinium—Urethral disorder—Tacrolimus—atopic dermatitis	0.00128	0.00604	CcSEcCtD
Aclidinium—Diabetes mellitus—Triamcinolone—atopic dermatitis	0.00127	0.00602	CcSEcCtD
Aclidinium—Diabetes mellitus—Methylprednisolone—atopic dermatitis	0.00127	0.006	CcSEcCtD
Aclidinium—Cough—Mometasone—atopic dermatitis	0.00124	0.00588	CcSEcCtD
Aclidinium—Headache—Fluocinonide—atopic dermatitis	0.00122	0.00578	CcSEcCtD
Aclidinium—Eye disorder—Tacrolimus—atopic dermatitis	0.00122	0.00576	CcSEcCtD
Aclidinium—Infection—Fluocinolone Acetonide—atopic dermatitis	0.00121	0.00572	CcSEcCtD
Aclidinium—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.0012	0.0057	CcSEcCtD
Aclidinium—Diarrhoea—Diphenhydramine—atopic dermatitis	0.0012	0.0057	CcSEcCtD
Aclidinium—Cardiac failure—Hydrocortisone—atopic dermatitis	0.0012	0.00569	CcSEcCtD
Aclidinium—Osteoarthritis—Prednisolone—atopic dermatitis	0.0012	0.00569	CcSEcCtD
Aclidinium—Nervous system disorder—Fluocinolone Acetonide—atopic dermatitis	0.00119	0.00565	CcSEcCtD
Aclidinium—Dry mouth—Mometasone—atopic dermatitis	0.00118	0.00561	CcSEcCtD
Aclidinium—Osteoarthritis—Hydrocortisone—atopic dermatitis	0.00117	0.00556	CcSEcCtD
Aclidinium—Mediastinal disorder—Tacrolimus—atopic dermatitis	0.00117	0.00555	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.00117	0.00553	CcSEcCtD
Aclidinium—Diarrhoea—Pimecrolimus—atopic dermatitis	0.00116	0.00551	CcSEcCtD
Aclidinium—Infection—Mometasone—atopic dermatitis	0.00115	0.00547	CcSEcCtD
Aclidinium—Diabetes mellitus—Dexamethasone—atopic dermatitis	0.00115	0.00546	CcSEcCtD
Aclidinium—Diabetes mellitus—Betamethasone—atopic dermatitis	0.00115	0.00546	CcSEcCtD
Aclidinium—Cardiac failure—Methylprednisolone—atopic dermatitis	0.00113	0.00535	CcSEcCtD
Aclidinium—Vomiting—Dimenhydrinate—atopic dermatitis	0.00112	0.00529	CcSEcCtD
Aclidinium—Vomiting—Diphenhydramine—atopic dermatitis	0.00112	0.00529	CcSEcCtD
Aclidinium—Osteoarthritis—Triamcinolone—atopic dermatitis	0.0011	0.00523	CcSEcCtD
Aclidinium—Osteoarthritis—Methylprednisolone—atopic dermatitis	0.0011	0.00522	CcSEcCtD
Aclidinium—Headache—Diphenhydramine—atopic dermatitis	0.0011	0.00521	CcSEcCtD
Aclidinium—Headache—Dimenhydrinate—atopic dermatitis	0.0011	0.00521	CcSEcCtD
Aclidinium—Vomiting—Pimecrolimus—atopic dermatitis	0.00108	0.00512	CcSEcCtD
Aclidinium—Vision blurred—Tacrolimus—atopic dermatitis	0.00107	0.00506	CcSEcCtD
Aclidinium—Headache—Pimecrolimus—atopic dermatitis	0.00106	0.00504	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.00105	0.00497	CcSEcCtD
Aclidinium—Cardiac failure—Dexamethasone—atopic dermatitis	0.00103	0.00487	CcSEcCtD
Aclidinium—Cardiac failure—Betamethasone—atopic dermatitis	0.00103	0.00487	CcSEcCtD
Aclidinium—Diabetes mellitus—Prednisone—atopic dermatitis	0.001	0.00475	CcSEcCtD
Aclidinium—Osteoarthritis—Dexamethasone—atopic dermatitis	0.001	0.00475	CcSEcCtD
Aclidinium—Osteoarthritis—Betamethasone—atopic dermatitis	0.001	0.00475	CcSEcCtD
Aclidinium—Cough—Tacrolimus—atopic dermatitis	0.000988	0.00468	CcSEcCtD
Aclidinium—Dry mouth—Tacrolimus—atopic dermatitis	0.000943	0.00447	CcSEcCtD
Aclidinium—Diarrhoea—Loratadine—atopic dermatitis	0.000926	0.00439	CcSEcCtD
Aclidinium—Infection—Tacrolimus—atopic dermatitis	0.000918	0.00435	CcSEcCtD
Aclidinium—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000906	0.00429	CcSEcCtD
Aclidinium—Infestation NOS—Hydrocortisone—atopic dermatitis	0.000904	0.00428	CcSEcCtD
Aclidinium—Infestation—Hydrocortisone—atopic dermatitis	0.000904	0.00428	CcSEcCtD
Aclidinium—Tachycardia—Tacrolimus—atopic dermatitis	0.000902	0.00427	CcSEcCtD
Aclidinium—Cardiac failure—Prednisone—atopic dermatitis	0.000894	0.00424	CcSEcCtD
Aclidinium—Osteoarthritis—Prednisone—atopic dermatitis	0.000873	0.00414	CcSEcCtD
Aclidinium—Vomiting—Loratadine—atopic dermatitis	0.00086	0.00408	CcSEcCtD
Aclidinium—Infestation NOS—Methylprednisolone—atopic dermatitis	0.000849	0.00402	CcSEcCtD
Aclidinium—Infestation—Methylprednisolone—atopic dermatitis	0.000849	0.00402	CcSEcCtD
Aclidinium—Headache—Loratadine—atopic dermatitis	0.000848	0.00402	CcSEcCtD
Aclidinium—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000832	0.00394	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000798	0.00378	CcSEcCtD
Aclidinium—Diarrhoea—Mometasone—atopic dermatitis	0.000795	0.00376	CcSEcCtD
Aclidinium—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000773	0.00366	CcSEcCtD
Aclidinium—Rhinitis—Triamcinolone—atopic dermatitis	0.000766	0.00363	CcSEcCtD
Aclidinium—Rhinitis—Methylprednisolone—atopic dermatitis	0.000764	0.00362	CcSEcCtD
Aclidinium—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000762	0.00361	CcSEcCtD
Aclidinium—Eye disorder—Hydrocortisone—atopic dermatitis	0.000758	0.00359	CcSEcCtD
Aclidinium—Vomiting—Mometasone—atopic dermatitis	0.000738	0.0035	CcSEcCtD
Aclidinium—Headache—Mometasone—atopic dermatitis	0.000728	0.00345	CcSEcCtD
Aclidinium—Eye disorder—Methylprednisolone—atopic dermatitis	0.000713	0.00338	CcSEcCtD
Aclidinium—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000687	0.00326	CcSEcCtD
Aclidinium—Vision blurred—Prednisolone—atopic dermatitis	0.000682	0.00323	CcSEcCtD
Aclidinium—Eye disorder—Dexamethasone—atopic dermatitis	0.000648	0.00307	CcSEcCtD
Aclidinium—Eye disorder—Betamethasone—atopic dermatitis	0.000648	0.00307	CcSEcCtD
Aclidinium—Diarrhoea—Tacrolimus—atopic dermatitis	0.000632	0.003	CcSEcCtD
Aclidinium—Vomiting—Tacrolimus—atopic dermatitis	0.000588	0.00278	CcSEcCtD
Aclidinium—Cough—Triamcinolone—atopic dermatitis	0.00058	0.00275	CcSEcCtD
Aclidinium—Headache—Tacrolimus—atopic dermatitis	0.000579	0.00274	CcSEcCtD
Aclidinium—Tachycardia—Prednisolone—atopic dermatitis	0.000576	0.00273	CcSEcCtD
Aclidinium—Infection—Hydrocortisone—atopic dermatitis	0.000573	0.00271	CcSEcCtD
Aclidinium—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000565	0.00268	CcSEcCtD
Aclidinium—Eye disorder—Prednisone—atopic dermatitis	0.000564	0.00267	CcSEcCtD
Aclidinium—Tachycardia—Hydrocortisone—atopic dermatitis	0.000563	0.00267	CcSEcCtD
Aclidinium—Dry mouth—Triamcinolone—atopic dermatitis	0.000554	0.00262	CcSEcCtD
Aclidinium—Infection—Triamcinolone—atopic dermatitis	0.000539	0.00256	CcSEcCtD
Aclidinium—Infection—Methylprednisolone—atopic dermatitis	0.000538	0.00255	CcSEcCtD
Aclidinium—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000531	0.00252	CcSEcCtD
Aclidinium—Tachycardia—Triamcinolone—atopic dermatitis	0.00053	0.00251	CcSEcCtD
Aclidinium—Tachycardia—Methylprednisolone—atopic dermatitis	0.000529	0.0025	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000498	0.00236	CcSEcCtD
Aclidinium—Vision blurred—Prednisone—atopic dermatitis	0.000495	0.00235	CcSEcCtD
Aclidinium—Infection—Dexamethasone—atopic dermatitis	0.000489	0.00232	CcSEcCtD
Aclidinium—Infection—Betamethasone—atopic dermatitis	0.000489	0.00232	CcSEcCtD
Aclidinium—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000483	0.00229	CcSEcCtD
Aclidinium—Nervous system disorder—Betamethasone—atopic dermatitis	0.000483	0.00229	CcSEcCtD
Aclidinium—Tachycardia—Dexamethasone—atopic dermatitis	0.000481	0.00228	CcSEcCtD
Aclidinium—Tachycardia—Betamethasone—atopic dermatitis	0.000481	0.00228	CcSEcCtD
Aclidinium—Infection—Prednisone—atopic dermatitis	0.000426	0.00202	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000425	0.00201	CcSEcCtD
Aclidinium—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000425	0.00201	CcSEcCtD
Aclidinium—Nervous system disorder—Prednisone—atopic dermatitis	0.000421	0.00199	CcSEcCtD
Aclidinium—Tachycardia—Prednisone—atopic dermatitis	0.000419	0.00198	CcSEcCtD
Aclidinium—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000395	0.00187	CcSEcCtD
Aclidinium—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000371	0.00176	CcSEcCtD
Aclidinium—Headache—Prednisolone—atopic dermatitis	0.00037	0.00175	CcSEcCtD
Aclidinium—Vomiting—Hydrocortisone—atopic dermatitis	0.000367	0.00174	CcSEcCtD
Aclidinium—Headache—Hydrocortisone—atopic dermatitis	0.000361	0.00171	CcSEcCtD
Aclidinium—Vomiting—Triamcinolone—atopic dermatitis	0.000345	0.00164	CcSEcCtD
Aclidinium—Vomiting—Methylprednisolone—atopic dermatitis	0.000344	0.00163	CcSEcCtD
Aclidinium—Headache—Triamcinolone—atopic dermatitis	0.00034	0.00161	CcSEcCtD
Aclidinium—Headache—Methylprednisolone—atopic dermatitis	0.000339	0.00161	CcSEcCtD
Aclidinium—Diarrhoea—Dexamethasone—atopic dermatitis	0.000337	0.0016	CcSEcCtD
Aclidinium—Diarrhoea—Betamethasone—atopic dermatitis	0.000337	0.0016	CcSEcCtD
Aclidinium—Vomiting—Dexamethasone—atopic dermatitis	0.000313	0.00148	CcSEcCtD
Aclidinium—Vomiting—Betamethasone—atopic dermatitis	0.000313	0.00148	CcSEcCtD
Aclidinium—Headache—Betamethasone—atopic dermatitis	0.000309	0.00146	CcSEcCtD
Aclidinium—Headache—Dexamethasone—atopic dermatitis	0.000309	0.00146	CcSEcCtD
Aclidinium—Diarrhoea—Prednisone—atopic dermatitis	0.000294	0.00139	CcSEcCtD
Aclidinium—Vomiting—Prednisone—atopic dermatitis	0.000273	0.00129	CcSEcCtD
Aclidinium—Headache—Prednisone—atopic dermatitis	0.000269	0.00127	CcSEcCtD
Aclidinium—BCHE—Metabolism—GLB1—atopic dermatitis	6.21e-05	0.00197	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	6.12e-05	0.00195	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—TAC1—atopic dermatitis	6.1e-05	0.00194	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—NPS—atopic dermatitis	6.1e-05	0.00194	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—CXCR3—atopic dermatitis	5.98e-05	0.0019	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCL27—atopic dermatitis	5.96e-05	0.0019	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—ADSL—atopic dermatitis	5.95e-05	0.00189	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CCR3—atopic dermatitis	5.95e-05	0.00189	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	5.87e-05	0.00187	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	5.87e-05	0.00187	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	5.85e-05	0.00186	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—TAC1—atopic dermatitis	5.84e-05	0.00186	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—NPS—atopic dermatitis	5.84e-05	0.00186	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	5.8e-05	0.00184	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—CXCL10—atopic dermatitis	5.77e-05	0.00183	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—CXCL10—atopic dermatitis	5.75e-05	0.00183	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—CXCR3—atopic dermatitis	5.73e-05	0.00182	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—CXCL10—atopic dermatitis	5.69e-05	0.00181	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—IL5—atopic dermatitis	5.67e-05	0.0018	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCL17—atopic dermatitis	5.58e-05	0.00178	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—NPS—atopic dermatitis	5.54e-05	0.00176	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—TAC1—atopic dermatitis	5.54e-05	0.00176	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—CXCR3—atopic dermatitis	5.43e-05	0.00173	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—IL5—atopic dermatitis	5.43e-05	0.00173	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCL17—atopic dermatitis	5.35e-05	0.0017	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—TAC1—atopic dermatitis	5.3e-05	0.00169	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—NPS—atopic dermatitis	5.3e-05	0.00169	CbGpPWpGaD
Aclidinium—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	5.27e-05	0.00167	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CXCR3—atopic dermatitis	5.2e-05	0.00165	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—IL5—atopic dermatitis	5.15e-05	0.00164	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CCL11—atopic dermatitis	5.14e-05	0.00163	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CCL11—atopic dermatitis	5.12e-05	0.00163	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CCL11—atopic dermatitis	5.07e-05	0.00161	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—FCER2—atopic dermatitis	5.07e-05	0.00161	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—FCER2—atopic dermatitis	5.05e-05	0.00161	CbGpPWpGaD
Aclidinium—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	5.04e-05	0.0016	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—FCER2—atopic dermatitis	5e-05	0.00159	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—KIF3A—atopic dermatitis	4.98e-05	0.00158	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—CCL5—atopic dermatitis	4.96e-05	0.00158	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—CCL5—atopic dermatitis	4.95e-05	0.00157	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—IL5—atopic dermatitis	4.93e-05	0.00157	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—CCL5—atopic dermatitis	4.9e-05	0.00156	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—CXCL10—atopic dermatitis	4.83e-05	0.00154	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—GLB1—atopic dermatitis	4.77e-05	0.00152	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—KIF3A—atopic dermatitis	4.77e-05	0.00152	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCL22—atopic dermatitis	4.71e-05	0.0015	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCL22—atopic dermatitis	4.7e-05	0.00149	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCL22—atopic dermatitis	4.65e-05	0.00148	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—CXCL10—atopic dermatitis	4.63e-05	0.00147	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CCR3—atopic dermatitis	4.61e-05	0.00147	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CCR3—atopic dermatitis	4.6e-05	0.00146	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—ADSL—atopic dermatitis	4.58e-05	0.00146	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CCR3—atopic dermatitis	4.55e-05	0.00145	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	4.52e-05	0.00144	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCL11—atopic dermatitis	4.5e-05	0.00143	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CMA1—atopic dermatitis	4.5e-05	0.00143	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—CCR5—atopic dermatitis	4.47e-05	0.00142	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—CCR5—atopic dermatitis	4.46e-05	0.00142	CbGpPWpGaD
Aclidinium—CHRM1—Circadian rythm related genes—MAPK8—atopic dermatitis	4.45e-05	0.00142	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—CCR5—atopic dermatitis	4.41e-05	0.0014	CbGpPWpGaD
Aclidinium—CHRM2—G alpha (i) signalling events—CXCL8—atopic dermatitis	4.41e-05	0.0014	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—CXCL10—atopic dermatitis	4.39e-05	0.0014	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCL11—atopic dermatitis	4.31e-05	0.00137	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CMA1—atopic dermatitis	4.31e-05	0.00137	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—TNF—atopic dermatitis	4.26e-05	0.00135	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—STAT6—atopic dermatitis	4.23e-05	0.00135	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CXCL10—atopic dermatitis	4.2e-05	0.00134	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCL27—atopic dermatitis	4.2e-05	0.00134	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CCR3—atopic dermatitis	4.19e-05	0.00133	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCL27—atopic dermatitis	4.18e-05	0.00133	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CCR3—atopic dermatitis	4.18e-05	0.00133	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—CCL5—atopic dermatitis	4.16e-05	0.00132	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCL27—atopic dermatitis	4.14e-05	0.00132	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CCR3—atopic dermatitis	4.13e-05	0.00132	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—NPS—atopic dermatitis	4.11e-05	0.00131	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—TAC1—atopic dermatitis	4.11e-05	0.00131	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—TAC1—atopic dermatitis	4.1e-05	0.0013	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—NPS—atopic dermatitis	4.1e-05	0.0013	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—TAC1—atopic dermatitis	4.06e-05	0.00129	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—NPS—atopic dermatitis	4.06e-05	0.00129	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—STAT6—atopic dermatitis	4.05e-05	0.00129	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	4.03e-05	0.00128	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CXCR3—atopic dermatitis	4.02e-05	0.00128	CbGpPWpGaD
Aclidinium—CHRM4—GPCR ligand binding—CXCL8—atopic dermatitis	4.01e-05	0.00128	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—CCL5—atopic dermatitis	3.98e-05	0.00127	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CXCR3—atopic dermatitis	3.98e-05	0.00127	CbGpPWpGaD
Aclidinium—CHRM5—GPCR ligand binding—CXCL8—atopic dermatitis	3.84e-05	0.00122	CbGpPWpGaD
Aclidinium—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	3.83e-05	0.00122	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—IL5—atopic dermatitis	3.82e-05	0.00122	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—IL5—atopic dermatitis	3.81e-05	0.00121	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—CCL5—atopic dermatitis	3.78e-05	0.0012	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—IL5—atopic dermatitis	3.77e-05	0.0012	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCL17—atopic dermatitis	3.77e-05	0.0012	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCL17—atopic dermatitis	3.75e-05	0.00119	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—CCR5—atopic dermatitis	3.75e-05	0.00119	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—TAC1—atopic dermatitis	3.73e-05	0.00119	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—NPS—atopic dermatitis	3.73e-05	0.00119	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—TAC1—atopic dermatitis	3.72e-05	0.00118	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—NPS—atopic dermatitis	3.72e-05	0.00118	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCL17—atopic dermatitis	3.72e-05	0.00118	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—NPS—atopic dermatitis	3.69e-05	0.00117	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—TAC1—atopic dermatitis	3.69e-05	0.00117	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCR3—atopic dermatitis	3.67e-05	0.00117	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CXCR3—atopic dermatitis	3.66e-05	0.00116	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CXCR3—atopic dermatitis	3.65e-05	0.00116	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CCL5—atopic dermatitis	3.62e-05	0.00115	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CXCR3—atopic dermatitis	3.61e-05	0.00115	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—CCR5—atopic dermatitis	3.59e-05	0.00114	CbGpPWpGaD
Aclidinium—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.55e-05	0.00113	CbGpPWpGaD
Aclidinium—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.54e-05	0.00113	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCR3—atopic dermatitis	3.51e-05	0.00112	CbGpPWpGaD
Aclidinium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	3.5e-05	0.00111	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—IL5—atopic dermatitis	3.47e-05	0.0011	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—IL5—atopic dermatitis	3.46e-05	0.0011	CbGpPWpGaD
Aclidinium—CHRM2—SIDS Susceptibility Pathways—IL6—atopic dermatitis	3.44e-05	0.00109	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—IL5—atopic dermatitis	3.43e-05	0.00109	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—CCR5—atopic dermatitis	3.4e-05	0.00108	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—KIF3A—atopic dermatitis	3.36e-05	0.00107	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—KIF3A—atopic dermatitis	3.35e-05	0.00106	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—KIF3A—atopic dermatitis	3.31e-05	0.00105	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—NPS—atopic dermatitis	3.27e-05	0.00104	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—TAC1—atopic dermatitis	3.27e-05	0.00104	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CCR5—atopic dermatitis	3.26e-05	0.00104	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	3.26e-05	0.00104	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CXCL10—atopic dermatitis	3.25e-05	0.00103	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CXCL10—atopic dermatitis	3.22e-05	0.00102	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CXCR3—atopic dermatitis	3.21e-05	0.00102	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—TAC1—atopic dermatitis	3.13e-05	0.000996	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—NPS—atopic dermatitis	3.13e-05	0.000996	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CXCR3—atopic dermatitis	3.07e-05	0.000977	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IL5—atopic dermatitis	3.04e-05	0.000967	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCL11—atopic dermatitis	3.04e-05	0.000965	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CMA1—atopic dermatitis	3.04e-05	0.000965	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCL11—atopic dermatitis	3.03e-05	0.000962	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CMA1—atopic dermatitis	3.03e-05	0.000962	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CMA1—atopic dermatitis	3e-05	0.000953	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCL11—atopic dermatitis	3e-05	0.000953	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CXCL10—atopic dermatitis	2.96e-05	0.000941	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CXCL10—atopic dermatitis	2.95e-05	0.000938	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CXCL10—atopic dermatitis	2.92e-05	0.000929	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IL5—atopic dermatitis	2.91e-05	0.000926	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—STAT6—atopic dermatitis	2.85e-05	0.000908	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—STAT6—atopic dermatitis	2.84e-05	0.000905	CbGpPWpGaD
Aclidinium—CHRM1—Circadian rythm related genes—IL6—atopic dermatitis	2.84e-05	0.000904	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—STAT6—atopic dermatitis	2.82e-05	0.000896	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CCL5—atopic dermatitis	2.81e-05	0.000892	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CCL5—atopic dermatitis	2.8e-05	0.000889	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CCL5—atopic dermatitis	2.77e-05	0.000881	CbGpPWpGaD
Aclidinium—CHRM1—GPCR ligand binding—CXCL8—atopic dermatitis	2.7e-05	0.00086	CbGpPWpGaD
Aclidinium—CHRM3—GPCR ligand binding—CXCL8—atopic dermatitis	2.7e-05	0.000857	CbGpPWpGaD
Aclidinium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.69e-05	0.000857	CbGpPWpGaD
Aclidinium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.68e-05	0.000854	CbGpPWpGaD
Aclidinium—CHRM2—GPCR ligand binding—CXCL8—atopic dermatitis	2.67e-05	0.000849	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CXCL10—atopic dermatitis	2.59e-05	0.000825	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CCL5—atopic dermatitis	2.55e-05	0.00081	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CCL5—atopic dermatitis	2.54e-05	0.000808	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CCR5—atopic dermatitis	2.53e-05	0.000804	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CCR5—atopic dermatitis	2.52e-05	0.000801	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CCL5—atopic dermatitis	2.51e-05	0.0008	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CCR5—atopic dermatitis	2.49e-05	0.000794	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CXCL10—atopic dermatitis	2.48e-05	0.00079	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCR3—atopic dermatitis	2.47e-05	0.000787	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCR3—atopic dermatitis	2.47e-05	0.000785	CbGpPWpGaD
Aclidinium—BCHE—Metabolism of proteins—CXCL8—atopic dermatitis	2.47e-05	0.000784	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCR3—atopic dermatitis	2.44e-05	0.000777	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CCR5—atopic dermatitis	2.29e-05	0.00073	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CCR5—atopic dermatitis	2.29e-05	0.000728	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—CXCL8—atopic dermatitis	2.27e-05	0.000721	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CCR5—atopic dermatitis	2.27e-05	0.000721	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCL5—atopic dermatitis	2.23e-05	0.00071	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—TAC1—atopic dermatitis	2.21e-05	0.000701	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—NPS—atopic dermatitis	2.21e-05	0.000701	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—TAC1—atopic dermatitis	2.2e-05	0.000699	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—NPS—atopic dermatitis	2.2e-05	0.000699	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—NPS—atopic dermatitis	2.18e-05	0.000692	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—TAC1—atopic dermatitis	2.18e-05	0.000692	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—CXCL8—atopic dermatitis	2.17e-05	0.00069	CbGpPWpGaD
Aclidinium—CHRM4—GPCR downstream signaling—IL2—atopic dermatitis	2.17e-05	0.000689	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CXCR3—atopic dermatitis	2.16e-05	0.000688	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CXCR3—atopic dermatitis	2.16e-05	0.000686	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCL5—atopic dermatitis	2.14e-05	0.00068	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CXCR3—atopic dermatitis	2.13e-05	0.000679	CbGpPWpGaD
Aclidinium—CHRM5—GPCR downstream signaling—IL2—atopic dermatitis	2.07e-05	0.00066	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—NGF—atopic dermatitis	2.07e-05	0.000657	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—CXCL8—atopic dermatitis	2.06e-05	0.000655	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IL5—atopic dermatitis	2.05e-05	0.000652	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IL5—atopic dermatitis	2.04e-05	0.00065	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IL5—atopic dermatitis	2.02e-05	0.000644	CbGpPWpGaD
Aclidinium—BCHE—Metabolism—PPARA—atopic dermatitis	2.02e-05	0.000641	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CCR5—atopic dermatitis	2.01e-05	0.00064	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—NGF—atopic dermatitis	1.98e-05	0.00063	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—CXCL8—atopic dermatitis	1.97e-05	0.000627	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—IL2—atopic dermatitis	1.97e-05	0.000626	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CCR5—atopic dermatitis	1.93e-05	0.000612	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—IL2—atopic dermatitis	1.88e-05	0.000599	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CXCL10—atopic dermatitis	1.75e-05	0.000556	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CXCL10—atopic dermatitis	1.74e-05	0.000554	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CXCL10—atopic dermatitis	1.73e-05	0.000549	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—NFKBIA—atopic dermatitis	1.7e-05	0.000542	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—NFKBIA—atopic dermatitis	1.63e-05	0.000519	CbGpPWpGaD
Aclidinium—CHRM3—Metabolism—PPARA—atopic dermatitis	1.55e-05	0.000493	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.53e-05	0.000486	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—CXCL8—atopic dermatitis	1.52e-05	0.000484	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—CXCL8—atopic dermatitis	1.51e-05	0.00048	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCL5—atopic dermatitis	1.5e-05	0.000479	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCL5—atopic dermatitis	1.5e-05	0.000477	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCL5—atopic dermatitis	1.49e-05	0.000472	CbGpPWpGaD
Aclidinium—CHRM1—GPCR downstream signaling—IL2—atopic dermatitis	1.46e-05	0.000464	CbGpPWpGaD
Aclidinium—CHRM3—GPCR downstream signaling—IL2—atopic dermatitis	1.46e-05	0.000463	CbGpPWpGaD
Aclidinium—CHRM2—GPCR downstream signaling—IL2—atopic dermatitis	1.44e-05	0.000458	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—NGF—atopic dermatitis	1.39e-05	0.000443	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—NGF—atopic dermatitis	1.39e-05	0.000442	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—CXCL8—atopic dermatitis	1.39e-05	0.000441	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—CXCL8—atopic dermatitis	1.38e-05	0.00044	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—NGF—atopic dermatitis	1.38e-05	0.000438	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—CXCL8—atopic dermatitis	1.37e-05	0.000436	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CCR5—atopic dermatitis	1.36e-05	0.000431	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CCR5—atopic dermatitis	1.35e-05	0.00043	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CCR5—atopic dermatitis	1.34e-05	0.000426	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—IL2—atopic dermatitis	1.33e-05	0.000422	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—IL2—atopic dermatitis	1.32e-05	0.00042	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—IL2—atopic dermatitis	1.31e-05	0.000416	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—CXCL8—atopic dermatitis	1.22e-05	0.000387	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—CXCL8—atopic dermatitis	1.16e-05	0.00037	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IL2—atopic dermatitis	1.16e-05	0.00037	CbGpPWpGaD
Aclidinium—CHRM4—Signaling by GPCR—IL6—atopic dermatitis	1.16e-05	0.000368	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—NFKBIA—atopic dermatitis	1.15e-05	0.000366	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—NFKBIA—atopic dermatitis	1.15e-05	0.000364	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—NFKBIA—atopic dermatitis	1.13e-05	0.000361	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IL2—atopic dermatitis	1.11e-05	0.000354	CbGpPWpGaD
Aclidinium—CHRM5—Signaling by GPCR—IL6—atopic dermatitis	1.11e-05	0.000352	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—MAPK8—atopic dermatitis	1.07e-05	0.00034	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—MAPK8—atopic dermatitis	1.02e-05	0.000326	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—CXCL8—atopic dermatitis	8.2e-06	0.000261	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—CXCL8—atopic dermatitis	8.17e-06	0.00026	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—CXCL8—atopic dermatitis	8.09e-06	0.000257	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IL2—atopic dermatitis	7.83e-06	0.000249	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IL2—atopic dermatitis	7.81e-06	0.000248	CbGpPWpGaD
Aclidinium—CHRM1—Signaling by GPCR—IL6—atopic dermatitis	7.79e-06	0.000248	CbGpPWpGaD
Aclidinium—CHRM3—Signaling by GPCR—IL6—atopic dermatitis	7.77e-06	0.000247	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IL2—atopic dermatitis	7.73e-06	0.000246	CbGpPWpGaD
Aclidinium—CHRM2—Signaling by GPCR—IL6—atopic dermatitis	7.69e-06	0.000245	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—MAPK8—atopic dermatitis	7.21e-06	0.000229	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—MAPK8—atopic dermatitis	7.19e-06	0.000229	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—MAPK8—atopic dermatitis	7.12e-06	0.000226	CbGpPWpGaD
Aclidinium—CHRM4—Signaling Pathways—IL6—atopic dermatitis	6.83e-06	0.000217	CbGpPWpGaD
Aclidinium—CHRM5—Signaling Pathways—IL6—atopic dermatitis	6.54e-06	0.000208	CbGpPWpGaD
Aclidinium—CHRM1—Signaling Pathways—IL6—atopic dermatitis	4.6e-06	0.000146	CbGpPWpGaD
Aclidinium—CHRM3—Signaling Pathways—IL6—atopic dermatitis	4.59e-06	0.000146	CbGpPWpGaD
Aclidinium—CHRM2—Signaling Pathways—IL6—atopic dermatitis	4.54e-06	0.000145	CbGpPWpGaD
